- Email: [email protected]
Keyword index to volume 19
EUROPEANJOURNALOF PHARMACOLOGY19 (1972) 401-404. NORTH-HOLLANDPUBLISHINGCOMPANY
K E Y W O R D I N D E X TO V O L U M E 1 9
Absorption rates 19 (1972) 366 Acetylcholinesterase 19 (1972) 199 Acute and chronic effects 19 (1972) 380 Adenosine 19 (1972) 246,343 Adenosine analogues 19 (1972) 246 Adenylcyclase 19 (1972) 18, 297 Adrenalectomy 19 (1972) 98 Adrenaline 19 (1972) 18 Adrenal medulla 19 (1972) 297 ~-Adrenergic blocking agents 19 (1972) 210 Adrenergic-cholinergic interaction 19 (1972) 145 Adrenergic innervation 19 (1972) 79 Adrenergic receptor 19 (1972) 79 /3-Adrenoreceptor stimulants, selective 19 (1972) 371 Agonist-antagonist 19 (1972) 218 Amine turnover 19 (1972) 25 6-Aminodopamine 19 (1972) 391 Amphetamine 19 (1972) 56, 98,223, 276, 318 Amphetamine metabolism 19 (1972) 52 Analgesia 19 (1972) 310 Angiotensin II 19 (1.972) 223 Anorexia 19 (1972) 318 Anoxia survival time 19 (1972) 357 Antidepressant drugs 19 (1972) 43 Antiemetic 19 (1972) 165 Antiparkinsonism drugs 19 (1972) 43 Aorta 19 (1972) 239 Apomorphine 19 (1972) 115 Arteries 19 (1972) 137 Ascorbic acid absorption 19 (1972) 140 Asymmetric effects 19 (1972) 231 ATP 19 (1972) 137, 343 ATPase activity 19 (1972) 137 Atria 19 (1972) 137 Atrium 19 (1972) 56 AV node 19 (1972) 351 AV node artery 19 (1972) 351 Baroreceptor reflex BC 105 Behavior
19 (1972) 210 19 (1972) 156 19 (1972) 310
Behavioral stimulation Biliary excretion Blood pressure Blood-pressure changes Blood vessel Body temperature Bradykinin Brain catecholamines Brain choline acetylase Brain growth Brain monoamines Brain parts Ca2+
19 (1972) 231 19 (1972) 366 19 (1972) 246 19 (1972) 160 19 (1972) 239 19 (1972) 52,357 19 (1972) 171 19 (1972) 231 19 (1972) 145 19 (1972) 156 19 (1972) 43, 145 19 (1972) 199
19 (1972) 67 Ca ions 19 (1972) 330 Carbachol 19(1972) 301 Carbon monoxide 19(1972) 385 Cardiac glycosides 19 (1972) 291,566 Cardiac phosphorylase activity 19 (1972) 12 Cardiotoxicity 19 (1972) 294 Carrageenin inflammation 19 (1972) 191 Catalepsy 19 (1972) 119 Catecholamine 19 (1972) 56 Catecholamine biosynthesis 19 (1972) 123 Catecholamines 19 (1972) 25,318,351 Catechol-O-methyl transferase 19 (1972) 35 Cell-free preparations 19 (1972) 297 Central adrenergic receptors 19 (1972) 210 Central vagus activity 19 (1972) 203 Cerebellectomy 19 (1972) 160 Cerebral blood flow 19 (1972) 385 Cervical spinal section 19 (1972) 301 C-fibres 19 (1972) 94 Chemical sympathectomy 19 (1972) 391 Chlorimipramine 19 (1972) 112 Chlorpromazine 19 (1972) 119 Chorda tympani 19 (1972) 301 Clonidine 19 (1972) 203,210 Computer stimulations 19 (1972) 323 Conduction blocking action 19 (1972) 267 Cyclic AMP 19 (1972) 12,130, 134, 305 Cyclic nucleotide phosphodiesterase 19 (1972) 134
402 Cyproheptadine
Keyword index to volume 19
19 (1972)156
Decarboxylase inhibition 19 (1972) 112 Die thanolamine-rutin 19 (1972) 218 Digitalis 19 (1972) 151,291 Digoxin 19 (1972) 294 5,6-Dihydroxyindole 19 (1972) 391 5,6-Dihydroxytryptamine 19 (1972) 288 Dimethoxyethylamine-mtin 19 (1972) 218 1-(2,4-Dime thylanilino) -3-isopropylamino-2-propanol 19 (1972) 285 Diphenylhydantoin 19 (1972) 94 Dipyridamole 19 (1972) 343 Distribution 19 (1972) 239 Diurnal thyroid blockade 19 (1972) 104 Dopamine 19 (1972) 35, 56, 115,145, 281,391 Dopamine-metabolism 19 (1972) 276 19 (1972) 115 Dopamine receptors 19 (1972) 43 Dopamine-receptor stimulants 19 (1972) 52, 126, 294 Drug interaction 19 (1972) 323 Drug metabolism 19 (1972) 330 Drug-receptor interactions 19 (1972) 276 Drug tolerance Edrophonium Electrical activity Electrogenic sodium pump Endogenous noradrenaline Ethanol Excitatory behaviour Exogenous noradrenaline Extensor reflex Extraneuronal binding Fenfluramine First-pass effect Free acidity Frequency facilitation Goitres Granulated vesicles Guinea pigs Guinea-pig trachea and atria Gut 2-Halogenoethylamines Heart Heart rate
19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972)
260 130 94 267 218 52 267 25 239
19 (1972) 52, 276, 19 (1972) 19 (1972) 19 (1972)
318 323 389 88
19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972)
104 251 104 371 343
19 (1972) 67 19 (1972) 130, 223 19 (1972) 246
19 (1972) 260 Hemicholinium-3 19 (1972) 343 Hexobendine 19 (1972) 389 Histamine 19 (1972) 180 Histamine release 19 (1972) 25 Histochemical amine analysis 19 (1972) 276 Homovanillic acid 19 (1972) 112 5-HT 19 (1972) 112 5-HTP syndrome 19 (1972) 380 Hydrochlorothiazide 19 (1972) 145 5-Hydroxydopamine 19 (1972) 115,145, 231,391 6-Hydroxydopamine 19 (1972) 218 Hydroxyl moiety 19 (1972)25 5-Hydroxytryp tamine 35, 126, 156, 288 19 (1972) 310 Hypothermia Ileum Inestinal metabolism Iodothyronine formation Isomeric-ratio Isoprenaline-induced depressor response Isoprenaline-induced tachycardia Isoproterenol
19 (1972) 19 (1972) 19 (1972) 19 (1972)
Leucopenia Lipolysis Local anesthetics Lysosomes
19 (1972) 19 (1972) 19 (1972) 19 (1972)
137 366 104 79
19 (1972) 285 19 (1972) 285 19 (1972) 1 191 98 67 191
Mammalian aorta 19 (1972) 79 MAO inhibition 19 (1972) 231 McNeil-A-343 19 (1972) 12 Medial raphe nucleus 19 (1972) 35 Melanins 19 (1972) 391 Membranes 19 (1972) 67 Mesenteric arteries, perfused 19 (1972) 380 5-Methoxy-N,N-dirnethyltryptamine 19 (1972) 25 Methysergide 19 (1972) 156 Mg ions 19 (1972) 330 Mice 19 (1972) 104 Microfilaments 19 (1972) 88 Microtubules 19 (1972) 88 Midbrain raphe 19 (1972) 318 Monoamine oxidase 19 (1972) 35 Monoamine oxidase inhibitors 19 (1972) 126 Morphine 19 (1972) 119, 123 Motor activity 19 (1972) 357
Keyword index to volume 19
Mouse
19(1972) 199
Naloxone 19 (1972) 119 Naphazoline 19 (1972) 203 Neonatal circulation 19 (1972) 171 Neuromuscular transmission 19 (1972) 88 Neuronal and receptor function 19 (1972) 380 Neuronal binding 19 (1972) 239 Neurotransmitters 19 (1972) 67, 343 Nicotine 19 (1972) 385 1-(4'-Nitrophenyl)-2-isopropylaminoethanol 19 (1972) 285 Non steroidal anti-inflammatory drugs 19 (1972) 191 Noradrenaline 12 (1972) 18, 56, 115, 239, 251 Noradrenaline released by electrical stimuli, nicotine and KC1 19 (1972) 267 Norepinephrine 19 (1972) 126, 223 Normotensive rat atria 19 (1972) 1 Nystatin inflammation 19 (1972) 191 Obidoxime 6-OH-dopamine Oscillation Ouabain Pacemaker Papaverine derivatives Parkinsons disease Pentobarbitone Perphenazine Pharmacokinetic models Phenformin Phenitrone Phenoxybenzamine Phenylephrine Pineal nerves Plasma histamine Portal blood flow Potassium Potassium canrenoate Potassium chloride Pre-hypertensive status Propanidid Prostaglandin Protection of receptors PTU kinetics Purinergic nerves Purkinje fibers
19 (1972) 19 (1972) 19 (1972) 19 (1972)
199 318 351 151
19 (I 972) 351 19 (1972) 134 19 (1972) 43 19 (1972) 160 19 (1972) 115, 165 19 (1972) 323 19 (1972) 389 19 (1972) 310 19 (1972) 239, 351 19 (1972) 1 19 (1972) 251 19 (1972) 180 19 (1972) 366 19 (1972) 1 19 (1972) 151 19 (1972) 151 19 (1972) 1 19 (1972) 180 19 (1972) 18, 305 19 (1972) 330 19 (1972) 104 19 (1972) 343 19 (1972) 291
Rat Receptor blockade Receptors c~-Receptors /3-Receptors Reflex bradycardia Release Renal medulla Reserpine Reserpine blockade Resorcinol derivatives Retina Ro 4-4602 Route of administration
403 19 (1972) 52 19 (1972) 115 19 (1972) 171 19 (1972) 18, 67 19 (1972) 18 19 (1972) 203 19 (1972) 305 19 (1972) 305 19 (1972) 56, 156 19 (1972) 267 19 (1972) 371 19 (1972) 56 19 (1972) 112 19 (1972) 323
Satin 19 (1972) 199 Saturable absorption 19 (1972) 140 Serotonin 19 (1972) 281,318 Sexual behaviour 19 (1972) 288 Single unit activity 19 (1972) 165 Spinal cord 19 (1972) 126 Spironolactone 19 (1972) 151 Spontaneously hypertensive rat atria 19 (1972) 1 Stellate ganglia 19 (1972) 301 Stereotypy 19 (1972) 115 Steroidal anti-inflammatory drugs 19 (1972) 191 Stimulants, central 19 (1972) 43 Stimulation of central vagal stump 19 (1972) 160 Stimulation of noradrenaline release 19 (1972) 267 Storage pools 19 (1972) 281 Striatal DA metabolism 19 (1972) 119 Striatum 19 (1972) 35 Striatum, rat 19 (1972) 281 Substantia nigra 19 (1972) 35 Supersensitivity 19 (1972) 115 Synthetic cardenolides 19 (1972) 291 Taenia 19 (1972) 260 A9-Tetrahydrocannabinol 19 (1972) 301,310 Tetrodotoxin 19 (1972) 351 Theophylline 19 (1972) 134 Thiopentone 19 (1972) 180 Thyroid-phenothiazines interaction 19 (1972) 357 Thyrotoxicosis 19 (1972) 12 Tobacco smoke 19 (1972) 385 Transmitter mobilization 19 (1972) 88 Tricyclic antidepressants 19 (1972) 126, 294 Tyramine 19 (1972) 12, 223,251
Keyword index to volume 19
404
Tyrosine hydroxylase
19 (1972)123
Umbilical cord Unilateral intraventricular injections
19(1972) 171 19(1972) 231
Vagal cardioinhibition Vagus Vascular smooth muscle
19 (1972) 210 19 (1972) 301 19 (1972) 134, 171
Vas deferens Vasopressin Ventricle Ventricular tachycardia Vesicle compartments Vestibular nuclei ZIO reaction
19 (1972) 56, 19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972)
137 305 56 151 251 165
19 (1972) 251
K E Y W O R D I N D E X TO V O L U M E 1 9
Absorption rates 19 (1972) 366 Acetylcholinesterase 19 (1972) 199 Acute and chronic effects 19 (1972) 380 Adenosine 19 (1972) 246,343 Adenosine analogues 19 (1972) 246 Adenylcyclase 19 (1972) 18, 297 Adrenalectomy 19 (1972) 98 Adrenaline 19 (1972) 18 Adrenal medulla 19 (1972) 297 ~-Adrenergic blocking agents 19 (1972) 210 Adrenergic-cholinergic interaction 19 (1972) 145 Adrenergic innervation 19 (1972) 79 Adrenergic receptor 19 (1972) 79 /3-Adrenoreceptor stimulants, selective 19 (1972) 371 Agonist-antagonist 19 (1972) 218 Amine turnover 19 (1972) 25 6-Aminodopamine 19 (1972) 391 Amphetamine 19 (1972) 56, 98,223, 276, 318 Amphetamine metabolism 19 (1972) 52 Analgesia 19 (1972) 310 Angiotensin II 19 (1.972) 223 Anorexia 19 (1972) 318 Anoxia survival time 19 (1972) 357 Antidepressant drugs 19 (1972) 43 Antiemetic 19 (1972) 165 Antiparkinsonism drugs 19 (1972) 43 Aorta 19 (1972) 239 Apomorphine 19 (1972) 115 Arteries 19 (1972) 137 Ascorbic acid absorption 19 (1972) 140 Asymmetric effects 19 (1972) 231 ATP 19 (1972) 137, 343 ATPase activity 19 (1972) 137 Atria 19 (1972) 137 Atrium 19 (1972) 56 AV node 19 (1972) 351 AV node artery 19 (1972) 351 Baroreceptor reflex BC 105 Behavior
19 (1972) 210 19 (1972) 156 19 (1972) 310
Behavioral stimulation Biliary excretion Blood pressure Blood-pressure changes Blood vessel Body temperature Bradykinin Brain catecholamines Brain choline acetylase Brain growth Brain monoamines Brain parts Ca2+
19 (1972) 231 19 (1972) 366 19 (1972) 246 19 (1972) 160 19 (1972) 239 19 (1972) 52,357 19 (1972) 171 19 (1972) 231 19 (1972) 145 19 (1972) 156 19 (1972) 43, 145 19 (1972) 199
19 (1972) 67 Ca ions 19 (1972) 330 Carbachol 19(1972) 301 Carbon monoxide 19(1972) 385 Cardiac glycosides 19 (1972) 291,566 Cardiac phosphorylase activity 19 (1972) 12 Cardiotoxicity 19 (1972) 294 Carrageenin inflammation 19 (1972) 191 Catalepsy 19 (1972) 119 Catecholamine 19 (1972) 56 Catecholamine biosynthesis 19 (1972) 123 Catecholamines 19 (1972) 25,318,351 Catechol-O-methyl transferase 19 (1972) 35 Cell-free preparations 19 (1972) 297 Central adrenergic receptors 19 (1972) 210 Central vagus activity 19 (1972) 203 Cerebellectomy 19 (1972) 160 Cerebral blood flow 19 (1972) 385 Cervical spinal section 19 (1972) 301 C-fibres 19 (1972) 94 Chemical sympathectomy 19 (1972) 391 Chlorimipramine 19 (1972) 112 Chlorpromazine 19 (1972) 119 Chorda tympani 19 (1972) 301 Clonidine 19 (1972) 203,210 Computer stimulations 19 (1972) 323 Conduction blocking action 19 (1972) 267 Cyclic AMP 19 (1972) 12,130, 134, 305 Cyclic nucleotide phosphodiesterase 19 (1972) 134
402 Cyproheptadine
Keyword index to volume 19
19 (1972)156
Decarboxylase inhibition 19 (1972) 112 Die thanolamine-rutin 19 (1972) 218 Digitalis 19 (1972) 151,291 Digoxin 19 (1972) 294 5,6-Dihydroxyindole 19 (1972) 391 5,6-Dihydroxytryptamine 19 (1972) 288 Dimethoxyethylamine-mtin 19 (1972) 218 1-(2,4-Dime thylanilino) -3-isopropylamino-2-propanol 19 (1972) 285 Diphenylhydantoin 19 (1972) 94 Dipyridamole 19 (1972) 343 Distribution 19 (1972) 239 Diurnal thyroid blockade 19 (1972) 104 Dopamine 19 (1972) 35, 56, 115,145, 281,391 Dopamine-metabolism 19 (1972) 276 19 (1972) 115 Dopamine receptors 19 (1972) 43 Dopamine-receptor stimulants 19 (1972) 52, 126, 294 Drug interaction 19 (1972) 323 Drug metabolism 19 (1972) 330 Drug-receptor interactions 19 (1972) 276 Drug tolerance Edrophonium Electrical activity Electrogenic sodium pump Endogenous noradrenaline Ethanol Excitatory behaviour Exogenous noradrenaline Extensor reflex Extraneuronal binding Fenfluramine First-pass effect Free acidity Frequency facilitation Goitres Granulated vesicles Guinea pigs Guinea-pig trachea and atria Gut 2-Halogenoethylamines Heart Heart rate
19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972)
260 130 94 267 218 52 267 25 239
19 (1972) 52, 276, 19 (1972) 19 (1972) 19 (1972)
318 323 389 88
19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972)
104 251 104 371 343
19 (1972) 67 19 (1972) 130, 223 19 (1972) 246
19 (1972) 260 Hemicholinium-3 19 (1972) 343 Hexobendine 19 (1972) 389 Histamine 19 (1972) 180 Histamine release 19 (1972) 25 Histochemical amine analysis 19 (1972) 276 Homovanillic acid 19 (1972) 112 5-HT 19 (1972) 112 5-HTP syndrome 19 (1972) 380 Hydrochlorothiazide 19 (1972) 145 5-Hydroxydopamine 19 (1972) 115,145, 231,391 6-Hydroxydopamine 19 (1972) 218 Hydroxyl moiety 19 (1972)25 5-Hydroxytryp tamine 35, 126, 156, 288 19 (1972) 310 Hypothermia Ileum Inestinal metabolism Iodothyronine formation Isomeric-ratio Isoprenaline-induced depressor response Isoprenaline-induced tachycardia Isoproterenol
19 (1972) 19 (1972) 19 (1972) 19 (1972)
Leucopenia Lipolysis Local anesthetics Lysosomes
19 (1972) 19 (1972) 19 (1972) 19 (1972)
137 366 104 79
19 (1972) 285 19 (1972) 285 19 (1972) 1 191 98 67 191
Mammalian aorta 19 (1972) 79 MAO inhibition 19 (1972) 231 McNeil-A-343 19 (1972) 12 Medial raphe nucleus 19 (1972) 35 Melanins 19 (1972) 391 Membranes 19 (1972) 67 Mesenteric arteries, perfused 19 (1972) 380 5-Methoxy-N,N-dirnethyltryptamine 19 (1972) 25 Methysergide 19 (1972) 156 Mg ions 19 (1972) 330 Mice 19 (1972) 104 Microfilaments 19 (1972) 88 Microtubules 19 (1972) 88 Midbrain raphe 19 (1972) 318 Monoamine oxidase 19 (1972) 35 Monoamine oxidase inhibitors 19 (1972) 126 Morphine 19 (1972) 119, 123 Motor activity 19 (1972) 357
Keyword index to volume 19
Mouse
19(1972) 199
Naloxone 19 (1972) 119 Naphazoline 19 (1972) 203 Neonatal circulation 19 (1972) 171 Neuromuscular transmission 19 (1972) 88 Neuronal and receptor function 19 (1972) 380 Neuronal binding 19 (1972) 239 Neurotransmitters 19 (1972) 67, 343 Nicotine 19 (1972) 385 1-(4'-Nitrophenyl)-2-isopropylaminoethanol 19 (1972) 285 Non steroidal anti-inflammatory drugs 19 (1972) 191 Noradrenaline 12 (1972) 18, 56, 115, 239, 251 Noradrenaline released by electrical stimuli, nicotine and KC1 19 (1972) 267 Norepinephrine 19 (1972) 126, 223 Normotensive rat atria 19 (1972) 1 Nystatin inflammation 19 (1972) 191 Obidoxime 6-OH-dopamine Oscillation Ouabain Pacemaker Papaverine derivatives Parkinsons disease Pentobarbitone Perphenazine Pharmacokinetic models Phenformin Phenitrone Phenoxybenzamine Phenylephrine Pineal nerves Plasma histamine Portal blood flow Potassium Potassium canrenoate Potassium chloride Pre-hypertensive status Propanidid Prostaglandin Protection of receptors PTU kinetics Purinergic nerves Purkinje fibers
19 (1972) 19 (1972) 19 (1972) 19 (1972)
199 318 351 151
19 (I 972) 351 19 (1972) 134 19 (1972) 43 19 (1972) 160 19 (1972) 115, 165 19 (1972) 323 19 (1972) 389 19 (1972) 310 19 (1972) 239, 351 19 (1972) 1 19 (1972) 251 19 (1972) 180 19 (1972) 366 19 (1972) 1 19 (1972) 151 19 (1972) 151 19 (1972) 1 19 (1972) 180 19 (1972) 18, 305 19 (1972) 330 19 (1972) 104 19 (1972) 343 19 (1972) 291
Rat Receptor blockade Receptors c~-Receptors /3-Receptors Reflex bradycardia Release Renal medulla Reserpine Reserpine blockade Resorcinol derivatives Retina Ro 4-4602 Route of administration
403 19 (1972) 52 19 (1972) 115 19 (1972) 171 19 (1972) 18, 67 19 (1972) 18 19 (1972) 203 19 (1972) 305 19 (1972) 305 19 (1972) 56, 156 19 (1972) 267 19 (1972) 371 19 (1972) 56 19 (1972) 112 19 (1972) 323
Satin 19 (1972) 199 Saturable absorption 19 (1972) 140 Serotonin 19 (1972) 281,318 Sexual behaviour 19 (1972) 288 Single unit activity 19 (1972) 165 Spinal cord 19 (1972) 126 Spironolactone 19 (1972) 151 Spontaneously hypertensive rat atria 19 (1972) 1 Stellate ganglia 19 (1972) 301 Stereotypy 19 (1972) 115 Steroidal anti-inflammatory drugs 19 (1972) 191 Stimulants, central 19 (1972) 43 Stimulation of central vagal stump 19 (1972) 160 Stimulation of noradrenaline release 19 (1972) 267 Storage pools 19 (1972) 281 Striatal DA metabolism 19 (1972) 119 Striatum 19 (1972) 35 Striatum, rat 19 (1972) 281 Substantia nigra 19 (1972) 35 Supersensitivity 19 (1972) 115 Synthetic cardenolides 19 (1972) 291 Taenia 19 (1972) 260 A9-Tetrahydrocannabinol 19 (1972) 301,310 Tetrodotoxin 19 (1972) 351 Theophylline 19 (1972) 134 Thiopentone 19 (1972) 180 Thyroid-phenothiazines interaction 19 (1972) 357 Thyrotoxicosis 19 (1972) 12 Tobacco smoke 19 (1972) 385 Transmitter mobilization 19 (1972) 88 Tricyclic antidepressants 19 (1972) 126, 294 Tyramine 19 (1972) 12, 223,251
Keyword index to volume 19
404
Tyrosine hydroxylase
19 (1972)123
Umbilical cord Unilateral intraventricular injections
19(1972) 171 19(1972) 231
Vagal cardioinhibition Vagus Vascular smooth muscle
19 (1972) 210 19 (1972) 301 19 (1972) 134, 171
Vas deferens Vasopressin Ventricle Ventricular tachycardia Vesicle compartments Vestibular nuclei ZIO reaction
19 (1972) 56, 19 (1972) 19 (1972) 19 (1972) 19 (1972) 19 (1972)
137 305 56 151 251 165
19 (1972) 251